Nachrichten zur Quest Diagnostics Inc. Aktie

These Companies Are Raising Guidance This Earnings Season

Both UnitedHealth and Quest Diagnostics have raised their current year outlooks, with each also seeing a favorable post-earnings reaction.…

Barclays raises Quest Diagnostics stock price target on momentum

Barclays raises Quest Diagnostics stock price target on momentum…

Quest Diagnostics: Volle Punktzahl im Robustheits-Check und neue Höchststände im Visier!

Die im Bereich der klinischen Labordiagnostik und Gesundheitsinformationen tätige Quest Diagnostics (DGX) (i.) ist ein Dauerläufer. Im Robustheits-Check von TraderFox…

Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up

DGX posts Q1 2026 earnings and revenue beat, with adjusted EPS up 13% and shares rising in pre-market trading.…

Retail Sales Stall as Dow Sets Record, S&P Falls | The Close 2/10/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

Quest Diagnostics Q4 Earnings & Revenues Beat Estimates, Stock Up

DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.…

Quest Diagnostics (DGX) Upgraded to Buy: Heres Why

Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects.…

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Here is how Quest Diagnostics (DGX) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.…

Quest Diagnostics CEO Davis sells $10.5 million in stock By Investing.com

Quest Diagnostics CEO Davis sells $10.5 million in stock…

Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue?

Quest Diagnostics (DGX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Will Hims & Hers Healths (HIMS) Lab Partnership Shape Its Path to Recurring Revenue Leadership?

Earlier this month, Hims & Hers Health announced the launch of Labs, a direct-to-consumer laboratory testing platform in partnership with…

Hims & Hers Health (HIMS) Launches Labs for Preventive Care

Key Takeaways: Hims & Hers Health (HIMS) launches Labs, a new preventive healthcare service, in partnership with…

Hims launches lab testing for preventive care

Hims & Hers launches lab testing with Quest Diagnostics, offering biomarker tests for $199 or $499 annually, as Dr. Patrick…

Hims & Hers Health launches lab testing with Quest Diagnostics

Hims & Hers Health launches lab testing with Quest Diagnostics - DJ…

Guardant Health (GH) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DATEWednesday, Oct. 29, 2025 at 4:30 p.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Helmy EltoukhyCo-Chief Executive Officer…

Quest Diagnostics director Pfeiffer sells $270k in stock By Investing.com

Quest Diagnostics director Pfeiffer sells $270k in stock…

Quest Diagnostics stock hits all-time high at 191.87 USD By Investing.com

Quest Diagnostics stock hits all-time high at 191.87 USD…

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Quest Diagnostics stock hits all-time high at $190.93 By Investing.com

Quest Diagnostics stock hits all-time high at $190.93…

Quest Diagnostics Raises 2025 Guidance

Key PointsQ2 revenue of $2.76 billion and adjusted EPS of $2.62 beat analyst estimates.Management raised full-year 2025 guidance for both…

Quest Diagnostics Boosts Its 2025 Outlook

Quest Diagnostics (NYSE:DGX) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year…

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?

Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

Motley Fool Investors Look Back at the First Half of 2025

In this podcast, Motley Fool senior analyst Anthony Schiavone and Motley Fool Asset Managements Chief Investment Strategist Bill Mann…

Quest Diagnostics (DGX) Upgraded to Buy: Heres What You Should Know

Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

HOLX vs. DGX: Which Womens Health-Focused Stock Is the Better Pick?

The womens health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more…

Quest Diagnostics (DGX) Down 1.8% Since Last Earnings Report: Can It Rebound?

Quest Diagnostics (DGX) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Should You Continue to Retain DGX Stock in Your Portfolio?

Quest Diagnostics continues to stay on investors radars due to its robust Advanced Diagnostics offerings and strength in acquisitions.…

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…

Quest Diagnostics: A Leader But Waiting For Better Price

…

Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?

Quest Diagnostics (DGX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Quest Diagnostics: Diagnostic-Spezialist profitiert von steigenden Behandlungszahlen und neuen KI-Tools zum Nachweis von Krebs!

Geschäftstreiber: Quest Diagnostics (DGX) gehört zu den weltweit führenden Anbietern klinischer Test- und Diagnostik-Verfahren. Neben Standard-Bluttests und diagnostischen Testverfahren zum…

Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?

Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Lets find out.…

Why Quest Diagnostics Stock Was Blasting Higher Today

Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company thats been…

Quest Diagnostics EPS Tops Predictions

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024.…

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?

It can be exciting to buy a stock that has been red hot and to jump on the bandwagon --…

EQS-News: Mainz Biomed gibt Vereinbarung mit Quest Diagnostics über die Bereitstellung von Labor-Services im Rahmen der klinischen Studie für den Darmkrebsfrüherkennungstest bekannt (deutsch)

Mainz Biomed gibt Vereinbarung mit Quest Diagnostics über die Bereitstellung von Labor-Services im Rahmen der klinischen Studie für den Darmkrebsfrüherkennungstest…

dpa-AFX ProFeed